Luqmani Raashid Ahmed, Pathare Sanjay, Kwok-Fai Tony Lee
Department of Rheumatology, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK.
Best Pract Res Clin Rheumatol. 2005 Apr;19(2):321-36. doi: 10.1016/j.berh.2004.11.002.
Vasculitis is considered to be secondary when it arises either in the context of a pre-existing connective tissue disease, as a result of direct infection with a limited range of organisms, especially viruses, or when it arises in response to exposure to a number of medications. Rheumatoid vasculitis is probably the most widely recognised form of secondary vasculitis, and in this article we review the incidence, clinical features and management of this condition. Infections may either trigger or cause some types of vasculitis. Drug therapy is a common cause of limited forms of vasculitis and may enhance our understanding of the mechanism of these diseases. The premature development of atherosclerosis in patients with existing connective tissue diseases or indeed primary vasculitis has been recognised for some time, and the underlying mechanisms are currently being studied. An appreciation of the complex and varied pathophysiology of secondary vasculitis may further our understanding of primary vasculitis.
当血管炎出现在已有的结缔组织病背景下、由有限种类的生物体(尤其是病毒)直接感染引起,或因接触多种药物而发生时,被认为是继发性的。类风湿性血管炎可能是继发性血管炎中最广为人知的形式,在本文中,我们将综述这种疾病的发病率、临床特征及治疗方法。感染可能触发或导致某些类型的血管炎。药物治疗是局限性血管炎的常见病因,可能增进我们对这些疾病发病机制的理解。已有结缔组织病患者或原发性血管炎患者中动脉粥样硬化的过早发生已被认识一段时间了,目前正在研究其潜在机制。了解继发性血管炎复杂多样的病理生理学可能会加深我们对原发性血管炎的理解。